Indoco Remedies rose 1.69% to Rs 231.4 after consolidated net profit spurted 71.62% to Rs 9.01 crore on 10% rise in total revenue from operations to to Rs 289.35 crore in Q3 December 2019 as against Q3 December 2018.
Consolidated profit before tax jumped 189% to Rs 11.07 crore in Q3 December 2019 as against Rs 3.83 crore in Q3 December 2018.
Commenting on Q3 resultsof the company, Aditi Panandikar, Managing Director, Indoeo Remedies, said, "During the third quarter, India Business continued the growth momentum by clocking a growth of 17%. International business registered a growth of 21 % in the third quarter. Considering the planned product launches in US, we expect the growth momentum in International business to continue".
Indoco Remedies is a fully integrated, research-oriented pharma company with presence in 55 countries.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
